FDA Approved: ALDACTONE — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Aldactone (spironolactone) from Pfizer. The approval updates the drug’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Edema
• Heart Failure
• Hyperaldosteronism
• Hypertension
• Liver Cirrhosis
• Nephrotic Syndrome

Drugs mentioned

• Aldactone (spironolactone)

Snippet

SUPPL AP for ALDACTONE (SPIRONOLACTONE)